Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Meeting Results for: December 2, 2009

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Tyvaso	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Renvela	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Embeda	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Stelara	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Simponi	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Vivitrol	New Drug Initial Review	Removed from Agenda	Prior Approval Required
Extavia	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Zenpep	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Lamictal XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Lamictal ODT	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Vyvanse	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Bromfed DM	New Drug Appeal	Require Prior Approval	Prior Approval Required
Savella	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Nascobal	New Drug Appeal	Require Prior Approval	Prior Approval Required
Saphris	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Moxatag	New Drug Appeal	Require Prior Approval	Prior Approval Required